Dom Lekarski S.A.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials

Phase

• Phase 11 trial
• Phase 41 trial

Status

• Completed2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Pfizer1 trial

Closed trials

• Completed

  Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

  NCT04362072· Phase 4· Pfizer· Source

• Completed

  A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

  NCT03468426· Phase 1· Boehringer Ingelheim· Source